The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Inositol: Research, Dosing, and Where to Buy in 2026

A research-first profile for Inositol (myionosttol, myo-inositol), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

Quick Answer

Inositol is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for Inositol, each linked to its source.

Key Facts
Supplement
  • Also indexed as myionosttol, myo-inositol.
  • 1 aggregated dosing-protocol mention from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Inositol?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Inositol Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

SpeakerSourceTimestampProtocolEvidence
Vigorous Steve FULL Quad Tear Recovery Protocol, HGH Serum Tests, Maximize Cardio... 01:23:19 Steve reported using myo-inositol trispyrophosphate (ITPP) continuously at approximately 300 mg/week to support oxygen-carrying capacity. anecdotal

Where to Buy Inositol in 2026

No tracked vendor recommendations for Inositol yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Inositol. Each line links to the original source.

  • "Results are reported as risk ratios or mean differences (MDs) with 95% confidence intervals (CIs)." · Greff D et al, 2023 PubMed
  • "Compared with metformin, treatment with myo-inositol + D-chiro-inositol was associated with a greater improvement in menstrual frequency (odds ratio 14.70 [95% confidence interval (CI) 2.31-93.58])." · Zhao H et al, 2021 PubMed

Research and Studies

8 PubMed-indexed papers reference Inositol. Top 8 shown.

Frequently Asked Questions

Is Inositol FDA-approved?

Inositol is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

What dosing is reported for Inositol?

This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.

How much research has been published on Inositol?

8 PubMed-indexed paper(s) reference Inositol in our current research feed. See the Research and Studies section above for citations.